sb 202190 has been researched along with Carcinoma, Merkel Cell in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Carcinoma, Merkel Cell: A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobson, SJ | 1 |
| Anene, A | 1 |
| Boyne, JR | 1 |
| Mankouri, J | 1 |
| Macdonald, A | 1 |
| Whitehouse, A | 1 |
1 other study available for sb 202190 and Carcinoma, Merkel Cell
| Article | Year |
|---|---|
Merkel cell polyomavirus small tumour antigen activates the p38 MAPK pathway to enhance cellular motility.
Topics: Antigens, Viral, Tumor; Carcinoma, Merkel Cell; Cell Movement; Gene Expression Regulation, Neoplasti | 2020 |